Status:
COMPLETED
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
Lead Sponsor:
Astellas Pharma S.A.S.
Conditions:
Clostridium Difficile Infection
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).
Eligibility Criteria
Inclusion
- Hospitalized patient
- Patient diagnosed with CDI
Exclusion
- Patient already included in this study
- Patient is taking part in a clinical trial in the field of CDI
Key Trial Info
Start Date :
September 3 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 17 2017
Estimated Enrollment :
296 Patients enrolled
Trial Details
Trial ID
NCT02214771
Start Date
September 3 2014
End Date
August 17 2017
Last Update
October 12 2017
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Site
Béthune, France
2
Site
Bordeaux, France
3
Site
Boulogne-Billancourt, France
4
Site
Caen, France